CLINICAL_TRIALS
trial_result
· 2021-02-16
Clinical Trial Update: Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL) [Phase 2]
Summary
Phase 2 study of AKCEA-ANGPTL3-LRx (ISIS 703802) in familial partial lipodystrophy has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Akcea Therapeutics | Conditions: Familial Partial Lipodystrophy | Phase 2 | Status: COMPLETED | Results posted: 2021-02-16